Impact of treating Staphylococcus aureus nasal carriers on wound infections in cardiac surgery

Journal of Hospital Infection

Volumn 64, Issue 2, 2006, Pages 162-168

  Konvalinka, A ^a   Errett, L ^b   Fong, I W ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cardiac surgery; Mupirocin; Prevention; Staphylococcus aureus; Wound infection

Indexed keywords

CEFAZOLIN; CLINDAMYCIN; PLACEBO; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIUM CARRIER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART SURGERY; HOSPITAL INFECTION; HUMAN; LEG; MAJOR CLINICAL STUDY; MALE; NOSE; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STERNUM; SURGICAL INFECTION; CORONARY ARTERY BYPASS GRAFT; CROSS INFECTION; DISEASE TRANSMISSION; HETEROZYGOTE; INTRADERMAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PREOPERATIVE CARE; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ANTI-BACTERIAL AGENTS; CARRIER STATE; CORONARY ARTERY BYPASS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NOSE; PREOPERATIVE CARE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 33750617956     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.06.010     Document Type: Article

References (36)

1. Olson D., and Lee Jr. J.T. Continuous 10 year wound infection surveillance: results, advantages, and unanswered questions. Arch Surg 125 (1990) 794-803
2. Greenblatt J., and Fisher R.A. Complications of cardiac surgery: infections. In: Kotler M.N., and Alfieri A. (Eds). Cardiac and non-cardiac complications of open heart surgery: prevention, diagnosis, and treatment (1992), Futura, New York 145-176
3. Sellick Jr. J.A., Stelmach M., and Mylotte J.M. Surveillance of surgical wound infection following open heart surgery. Infect Control Hosp Epidemiol 12 (1991) 591-596
4. Loop F.D., Lytle B.W., Cosgrove D.M., et al. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity and cost of care. Ann Thorac Surg 49 (1990) 179-187
5. Bor D.H., Rose R.M., Modlin J.F., Weintraub R., and Friedland G.H. Mediastinitis after cardiovascular surgery. Rev Infect Dis 5 (1983) 885-897
6. Demmy T.L., Park S.B., Liebler G.A., et al. Recent experience with major sternal wound complications. Ann Thorac Surg 49 (1990) 458-462
7. Culver D.H., Horan T.C., Gagnes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 91 Suppl 3B (1991) 152S-157S
8. Grossi E.A., Culliford A.T., Kreiger K.H., et al. A survey of 77 major infectious complications of median sternotomy: a review of 7949 consecutive operative procedures. Ann Thorac Surg 40 (1985) 214-223
9. Sarr M.G., Gott V.L., and Townsend T.R. Mediastinal infection after cardiac surgery. Ann Thorac Surg 38 (1984) 415-423
10. L'Ecuyer P.B., Murphy D., Little J.R., and Fraser V.J. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis 22 (1996) 424-429
11. Nelson R.M., and Dries D.J. The economic implications of infection in cardiac surgery. Ann Thorac Surg 42 (1986) 240-246
12. Boyce J.M., Potter-Bynoe G., and Dziobec L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol 11 (1990) 89-93
13. Kirkland K.B., Briggs J.P., Trivette S.L., Wilkinson W.E., and Sexton D.J. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20 (1999) 725-730
14. Fong I.W., Baker C.B., and McKee D.C. The value of prophylactic antibiotics in aorta-coronary bypass operations: a double-blind randomized trial. J Thorac Cardiovasc Surg 78 (1979) 908-913
15. Kluytmans J.A.J.W., Mouton J.W., Maat A.P.W.M., Manders M.A.A.J., Michel M.F., and Wagenvoort J.H.T. Surveillance of post operative infections in thoracic surgery. J Hosp Infect 27 (1994) 139-147
16. Perl T.M., and Golub J.E. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 32 (1998) S7-S16
17. Kluytmans J.A.J.W., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 (1997) 505-520
18. Wenzel R.P., and Perl T.M. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 31 (1995) 13-24
19. Laupland K., Church D., Mucenski M., Sutherland L., and Davies H. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 187 (2003) 1452-1459
20. von Eiff C., Becker K., Machka K., Stammer H., and Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344 (2001) 11-16
21. Kluytmans J.A.J.W., Mouton J.W., Ijzeman E.P.F., et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 171 (1995) 216-219
22. Fong IW, Laurel M, McMillan S, Bannatyne R. Association of Staphylococcus aureus nasal carriage with sternotomy wound infection. IDSA 33rd Annual Meeting, 16-18 September 1995, San Francisco, Abstract #63.
23. Gilbert D.N., Moellering R., and Sande M. The Stanford guide to antimicrobial therapy. 32nd edn. (2002), Antimicrobial Therapy Inc., Hyde Park, VT
24. Fong IW, Alhesayen A, MacMillan S, Bannatyne R, Errett L. The value of treating S. aureus nasal carriers with mupirocin ointment on sternal infection after cardiac surgery. IDSA 34th Annual Meeting, 18-20 September 1996, New Orleans, Abstract #181.
25. Boyce J.M. MRSA patients: proven methods to treat colonization and infection. J Hosp Infect 48 Suppl (2001) S9-S14
26. Chow J.W., and Yu V.L. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med 149 (1989) 1258-1262
27. Herwaldt L.A. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients. J Hosp Infect 40 Suppl (1998) S13-S23
28. Mody L., Kauffman C.A., McNeil S.A., Yapecki A.T., and Bradley S.F. Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis 37 (2003) 1467-1474
29. Tacconelli E., Carmeli Y., Aizer A., Ferreira G., Foreman M.G., and D'Agata E.M.C. Mupirocin prophylaxis to prevent Staphylococcus aureus infections in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 37 (2003) 1629-1638
30. Kluytmans J.A., Mouton J.W., VandenBergh M.F., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 17 (1996) 780-785
31. Cimochowski G.F., Harostock M.D., Brown R., Bernardi M., Alonzo N., and Loyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 71 (2001) 1572-1579
32. Gernaat von der Sluis A.J., Hoogenboom-Verdegaal A.M., Edixhoven P.J., and Spies-von Rooijen N.H. Prophylactic mupirocin could reduce orthopedic wound infections: 1044 patients treated with mupirocin compared with 1260 historical controls. Acta Orthop Scand 69 (1998) 412-414
33. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
34. Kalmeijer M.D., Coertjens H., van Nieuwland-Bollen P.M., et al. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 35 (2002) 353-358
35. Perez-Fontan M., Rosales M., Rodriguez-Carmona A., Falcon T.G., and Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 39 (2002) 337-341
36. Pena C., Fernandez-Sabe N., Dominguez M.A., et al. Staphylococcus aureus nasal carriage in patients on hemodialysis: role of cutaneous colonization. J Hosp Infect 58 (2004) 20-27